BrainsWay Ltd. (BWAY): Business Model Canvas

Key Partnerships

Collaborations with medical institutions: BrainsWay Ltd. has formed strategic partnerships with leading medical institutions to conduct clinical trials, research studies, and pilot programs. These alliances provide the company with access to top experts in the field of psychiatry and neurology, as well as valuable data and insights that help improve the effectiveness of their products.

Partnerships with global distributors: To expand their reach and distribution network, BrainsWay has established partnerships with global distributors who have a deep understanding of the local markets and regulatory requirements. These partnerships help the company penetrate new markets, increase sales, and provide better support to customers worldwide.

Research agreements with universities: By collaborating with universities and research institutions, BrainsWay is able to stay at the forefront of technological advancements and scientific discoveries in the field of neuromodulation. These partnerships enable the company to access cutting-edge research, leverage academic expertise, and develop innovative solutions that address unmet medical needs.

Strategic alliances with healthcare providers: BrainsWay works closely with healthcare providers such as hospitals, clinics, and mental health centers to ensure that their products are effectively integrated into clinical practice. These alliances help increase the adoption of BrainsWay's technology, improve patient outcomes, and drive revenue growth for the company.

Key Activities

BrainsWay Ltd. is dedicated to several key activities that drive the success of the company. These activities are essential components of the business model canvas and are crucial to achieving the company's strategic goals.

One of the primary key activities of BrainsWay Ltd. is the continuous research and development of Transcranial Magnetic Stimulation (TMS) technology. The company invests heavily in innovation to improve and expand its TMS technology, ensuring that it remains at the forefront of the industry. This includes developing new treatments, optimizing existing technology, and exploring new applications of TMS technology.

Another key activity of BrainsWay Ltd. is the manufacturing of medical devices. The company produces TMS devices that are used in the treatment of various neurological and psychiatric disorders. BrainsWay ensures that its devices meet high-quality standards and comply with regulatory requirements. The manufacturing process is carefully monitored to ensure consistency and reliability in the production of these medical devices.

BrainsWay Ltd. engages in marketing and promotional activities to increase awareness of its TMS technology and medical devices. The company utilizes various marketing channels to reach healthcare professionals, patients, and other key stakeholders. This includes attending conferences, hosting educational events, and developing promotional materials to highlight the benefits of TMS therapy.

Ensuring regulatory compliance is a critical key activity for BrainsWay Ltd. The company must adhere to strict regulations set forth by governmental agencies to market and sell its medical devices. BrainsWay actively monitors changes in regulations, conducts audits, and maintains documentation to demonstrate compliance. This includes obtaining necessary certifications, approvals, and licenses to operate in various markets around the world.

Building and maintaining strong customer relationships is a key focus for BrainsWay Ltd. The company strives to provide excellent customer service and support to healthcare professionals and patients who use its TMS technology. This includes offering training, technical support, and ongoing communication to ensure customer satisfaction.

BrainsWay Ltd. generates revenue primarily through the sale of its TMS devices and related services. The company also earns revenue from licensing agreements, partnerships, and collaborations with other organizations. BrainsWay continuously seeks new opportunities to diversify its revenue streams and expand its market reach.

Collaborating with key partners is essential for the success of BrainsWay Ltd. The company partners with healthcare providers, research institutions, distributors, and other stakeholders to enhance its product offerings and reach new markets. These partnerships help BrainsWay access specialized expertise, resources, and networks that are essential for growth and innovation.

• R&D expenses for technology development
• Manufacturing costs for medical devices
• Marketing and promotional expenses
• Regulatory compliance and quality assurance costs
• Employee salaries and benefits
• Operational expenses for facilities and infrastructure

Key Resources

BrainsWay Ltd. leverages a variety of key resources to support its innovative Transcranial Magnetic Stimulation (TMS) technology and drive the success of the business. These resources include:

• Patented TMS technology: BrainsWay holds numerous patents for its breakthrough TMS technology, giving the company a competitive edge in the market.
• Team of skilled engineers and scientists: The company boasts a team of highly skilled engineers and scientists who are dedicated to advancing the technology and developing new applications for TMS.
• Manufacturing facilities: BrainsWay operates state-of-the-art manufacturing facilities that produce the TMS devices with high precision and quality control.
• Strong sales and marketing teams: The company has robust sales and marketing teams in place to promote the technology, expand market reach, and drive customer acquisition.

These key resources are instrumental in supporting BrainsWay's mission to improve the lives of patients through innovative neuromodulation solutions.

Value Propositions

BrainsWay Ltd. offers a unique value proposition with its non-invasive brain disorder treatment options. By utilizing deep Transcranial Magnetic Stimulation (dTMS) technology, BrainsWay provides patients with a safe and effective alternative to traditional treatment methods for depression and obsessive-compulsive disorder (OCD).

• Non-invasive brain disorder treatment: BrainsWay's dTMS technology offers patients a non-invasive treatment option for brain disorders, eliminating the need for invasive procedures or medication that can have significant side effects.
• Clinically proven effectiveness for depression and OCD: BrainsWay's treatment has been clinically proven to effectively reduce symptoms of depression and OCD, providing patients with a viable treatment option that has shown positive results in clinical studies.
• Reduced side effects compared to traditional treatments: Unlike traditional treatments such as medication or electroconvulsive therapy (ECT) which can have significant side effects, BrainsWay's dTMS technology offers patients a treatment option with minimal side effects and discomfort.
• Accessible treatment options across multiple geographies: BrainsWay's technology is available in multiple geographies, making it accessible to patients around the world who are seeking innovative and effective treatment options for their brain disorders.

Customer Relationships

BrainsWay Ltd. places a high emphasis on building and maintaining strong customer relationships. We aim to provide direct support to healthcare providers utilizing our Deep TMS technology to ensure that they have all the resources and assistance they need to effectively utilize our devices for patient treatment.

• Direct Support to Healthcare Providers: Our team of dedicated professionals offers direct support to healthcare providers, assisting them with any technical issues or questions they may have regarding our Deep TMS technology. This ensures that our customers feel supported and confident in using our devices.
• Patient Education Programs: BrainsWay provides patient education programs to help healthcare providers educate their patients about the benefits of Deep TMS therapy. By offering educational resources and materials, we empower patients to make informed decisions about their treatment options.
• Ongoing Clinical Support and Training: We offer ongoing clinical support and training to healthcare providers to ensure that they are up to date with the latest advancements in Deep TMS therapy. Our team provides training sessions and workshops to help healthcare providers enhance their skills and knowledge in utilizing our technology.
• Customer Service for Device Maintenance and Queries: BrainsWay's customer service team is readily available to assist with any device maintenance issues or queries that healthcare providers may have. Our goal is to ensure that our customers can rely on us for prompt and effective support whenever they need it.

Channels

BrainsWay Ltd. utilizes a variety of channels to reach its target customers and promote its products:

• Direct sales force: BrainsWay employs a team of sales representatives who directly approach healthcare providers, hospitals, and clinics to promote the benefits of their innovative technology. These sales professionals are trained to educate potential customers on the features and uses of BrainsWay's products, ultimately leading to increased sales and market penetration.
• Online marketing and informational website: BrainsWay maintains a strong online presence through its website, where it provides detailed information about its products and services. The website serves as a valuable resource for both healthcare providers and patients seeking to learn more about non-invasive treatment options for various mental health disorders.
• Participation in medical and trade conferences: BrainsWay actively participates in industry conferences and trade shows to showcase its technology and establish relationships with potential customers and partners. By attending these events, BrainsWay is able to stay current on industry trends and network with key decision-makers in the healthcare sector.
• Distribution through healthcare technology providers: In addition to direct sales efforts, BrainsWay utilizes healthcare technology providers to distribute its products to a wider audience. By partnering with established distributors in the healthcare industry, BrainsWay is able to reach customers who may not have been directly targeted through their own sales channels.

Customer Segments

BrainsWay Ltd. serves several key customer segments in the healthcare industry:

• Hospitals and clinics: These facilities are the primary customers of BrainsWay's innovative technologies for the treatment of mental health disorders. Hospitals and clinics often invest in BrainsWay's products to offer cutting-edge treatment options to their patients.
• Mental health professionals: Psychiatrists, psychologists, and other mental health professionals are another important customer segment for BrainsWay. These professionals utilize BrainsWay's technology to provide non-invasive, effective treatment options for patients with depression and OCD.
• Patients suffering from depression and OCD: The ultimate beneficiaries of BrainsWay's products are individuals struggling with depression and OCD. BrainsWay's technology offers these patients a non-pharmacological and non-invasive treatment option that can significantly improve their quality of life.
• Healthcare institutions: In addition to individual hospitals and clinics, BrainsWay also serves larger healthcare institutions that are looking to invest in cutting-edge mental health treatments. These institutions may include universities, research hospitals, and government healthcare agencies.

Value Proposition

BrainsWay's value proposition lies in its innovative technology that offers a non-invasive, effective treatment option for patients with depression and OCD. By providing a safe and clinically proven alternative to traditional treatments, BrainsWay helps healthcare professionals improve patient outcomes and enhance their clinical practice.

• Non-invasive treatment: BrainsWay's Deep Transcranial Magnetic Stimulation (dTMS) technology offers a non-invasive treatment option for patients suffering from depression and OCD. This technology does not require anesthesia or sedation, making it a safer and more comfortable option for patients.
• Effective results: Clinical studies have shown that BrainsWay's dTMS technology can significantly reduce symptoms of depression and OCD in patients who have not responded to traditional treatments. By offering a novel approach to mental health therapy, BrainsWay helps patients achieve better outcomes and improve their quality of life.
• Clinician support: BrainsWay provides comprehensive training and support to mental health professionals who use its technology. By offering ongoing education and resources, BrainsWay helps clinicians implement dTMS therapy effectively and provide the best possible care for their patients.

Cost Structure

BrainsWay Ltd. incurs various costs in order to operate and grow its business. The cost structure includes the following key components:

• R&D Expenditure: BrainsWay invests significantly in research and development to continue innovating and improving its deep Transcranial Magnetic Stimulation (dTMS) technology. This includes costs associated with hiring scientists, conducting clinical trials, and developing new products and applications.
• Manufacturing and Operational Costs: The company has expenses related to the manufacturing of its dTMS devices and accessories. This includes raw materials, labor, equipment, and facilities costs. Operational expenses such as utilities, maintenance, and insurance also contribute to the overall cost structure.
• Sales and Marketing Expenses: BrainsWay allocates resources towards sales and marketing activities to promote its products and increase market penetration. This includes advertising, sales commissions, trade shows, promotional materials, and other marketing expenses to reach healthcare providers and patients.
• Regulatory and Compliance Costs: As a medical device company, BrainsWay must adhere to strict regulatory requirements and compliance standards. This includes costs associated with obtaining and maintaining regulatory approvals, conducting quality control measures, and ensuring ongoing compliance with relevant regulations in different markets.

Overall, the cost structure of BrainsWay Ltd. reflects the investment needed to support its research and development efforts, manufacture its dTMS devices, promote its products through sales and marketing activities, and ensure regulatory compliance in the healthcare industry.

Revenue Streams

BrainsWay Ltd. generates its revenue through various channels such as:

• Sale of TMS devices: BrainsWay sells its Transcranial Magnetic Stimulation (TMS) devices to hospitals, clinics, and research institutions around the world. These devices are used for the treatment of various neurological and psychiatric disorders, including depression, OCD, and addiction.
• Licensing of technology and patents: The company also generates revenue by licensing its innovative TMS technology and patents to other medical device manufacturers. This allows them to incorporate BrainsWay's cutting-edge technology into their own devices, broadening the reach of TMS therapy.
• Service and maintenance fees: BrainsWay offers service and maintenance contracts to its customers to ensure that their TMS devices are functioning optimally. This recurring revenue stream helps the company build long-term relationships with its clients and maintain a consistent cash flow.
• Collaborative research funding: BrainsWay collaborates with hospitals, universities, and research institutions on various clinical trials and studies to further validate the efficacy of TMS therapy. In return, the company receives funding for these collaborations, which not only generates revenue but also helps establish BrainsWay as a leader in the field of neuromodulation.

These revenue streams collectively contribute to BrainsWay's financial success and enable the company to continue developing innovative TMS solutions for patients suffering from a wide range of neurological and psychiatric conditions.